Electrochemical CO2 reduction (ECR) into value-added
multicarbon products is a promising approach for a carbon-neutral
economy. Heterogeneous molecular catalysts consist of atomic-precise,
controllable active sites with the potential to improve catalytic
activity by ligand design and engineering, yet most reported molecular
ECR catalysts do not exhibit multicarbon product selectivity. Herein,
we report the use of a copper–supramolecular pair as a crystalline
molecular catalyst to promote the formation of multicarbon products.
A combination of experimental and theoretical studies reveal that
the paired Cu sites work collaboratively to activate the CO2 substrate and facilitate the coupling of adsorbed CO species although
they are not bonded or bridged directly. The van der Waals interactions
between the substrate and the secondary coordination sphere also play
a crucial role in multicarbon product selectivity.
The electrochemical reduction of CO 2 has been recognized as one of the best strategies to reduce atmospheric CO 2 levels and achieve a carbon-neutral economy. We report here a copper complex, Cu(salan) 2 , as an efficient CO 2 reduction catalyst in basic aqueous media. Cu(salan) 2 exhibited different catalytic behaviors in nanocrystalline and graphene-supported forms. As nanocrystals, the complex did not show high catalytic activity and gradually decomposed into Cu 2 O upon electrolysis. However, when dispersed on a graphene matrix, Cu(salan) 2 exhibited a moderate-to-high CO selectivity and remained stable in long-term electrolysis. This work shows that siteisolation by dispersion of a molecular catalyst is an effective way to increase the catalyst stability and tune the product selectivity for CO 2 RR electrocatalysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.